CardioGenics is dedicated to develop more sensitive diagnostic test products to the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective 'to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies'. operating philosophy is that 'better diagnosis enhances the healthcare professionals' ability to provide better patient management which saves lives and reduces healthcare costs'. Fulfilling unmet clinical testing needs is the driving force behind CardioGenics' innovations.
The National Angel Capital Organization (NACO) accelerates a thriving, early-stage investing ecosystem in Canada by connecting individuals, groups, and other partners that support Angel-stage investing. NACO provides intelligence, tools and resources for its members; facilitates key connections across networks, borders and industries; and helps to inform policy affecting the Angel asset-class.